(Q52026784)

20 April 2018

title

The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia. (English)

1 reference

20 April 2018

0 references

1 reference

placebo-controlled trial

1 reference

based on heuristic

inferred from title

multi-infarct dementia

1 reference

Pantoni L

1

1 reference

20 April 2018

Bianchi C

2

1 reference

20 April 2018

Beneke M

3

1 reference

20 April 2018

Inzitari D

4

1 reference

20 April 2018

Wallin A

5

1 reference

20 April 2018

Erkinjuntti T

6

1 reference

20 April 2018

publication date

1 April 2000

1 reference

20 April 2018

Journal of the Neurological Sciences

published in

1 reference

20 April 2018

volume

175

1 reference

20 April 2018

issue

2

1 reference

20 April 2018

page(s)

116-123

1 reference

20 April 2018

The prevalence of dementia: a quantitative integration of the literature

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

The cost of dementia in Denmark: the Odense Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Preventable senility: a call for action against the vascular dementias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Propentofylline improves regional cerebral glucose metabolism and neuropsychologic performance in vascular dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

European Pentoxifylline Multi-Infarct Dementia Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Vascular dementia Italian sulodexide study (VA.D.I.S.S.). Clinical and biological results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Effect of nimodipine on memory after cerebral infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Human pial vascular reactions to intravenous Nimodipine-infusion during EC-IC bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Effects of calcium antagonists on intracerebral penetrating arterioles in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Comparison of the calcium entry blockers nimodipine and flunarizine on human cerebral and temporal arteries: role in cerebrovascular disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

An experimental study of the effect of nimodipine in primate subarachnoid haemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Therapeutic trial of intravenous nimodipine in patients with established cerebral vasospasm after rupture of intracranial aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Traumatic subarachnoid hemorrhage and its treatment with nimodipine. German tSAH Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Nimodipine in the treatment of old age dementias.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Short-term effects of the calcium channel blocker nimodipine (Bay-e-9736) in the management of primary degenerative dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Psychometrics in aging and dementia: advances in geropsychological assessments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

CT in the differential diagnosis between Alzheimer's disease and vascular dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Cerebral blood flow in dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

A new rating scale for dementia syndromes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

A rapid disability rating scale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

A new clinical scale for the staging of dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Guaranteed stimulus-processing in the evaluation of memory and learning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Patterns of performance on the Fuld Object Memory Evaluation in elderly inpatients with depression or dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Normative data for eight neuropsychological tests based on a Danish sample

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Word-list generation deficits in dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Why do frontal lobe symptoms predominate in vascular dementia with lacunes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Heterogeneity of vascular dementia: mechanisms and subgroups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

Multi-infarct dementia: prevention and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Posatirelin in the treatment of vascular dementia: a double-blind multicentre study vs placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900301-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(00)00301-4

1 reference

20 April 2018

1 reference

20 April 2018